BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36252564)

  • 21. [Merkel-cell carcinoma].
    Moll I
    Pathologe; 2019 Dec; 40(Suppl 3):350-354. PubMed ID: 31820040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T antigen-specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma.
    Hansen UK; Church CD; Carnaz Simões AM; Frej MS; Bentzen AK; Tvingsholm SA; Becker JC; Fling SP; Ramchurren N; Topalian SL; Nghiem PT; Hadrup SR
    J Clin Invest; 2024 Jan; 134(8):. PubMed ID: 38618958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.
    Tabachnick-Cherny S; Pulliam T; Rodriguez HJ; Fan X; Hippe DS; Jones DC; Moshiri AS; Smythe KS; Kulikauskas RM; Zaba LC; Paulson KG; Nghiem P
    Clin Cancer Res; 2024 Mar; 30(6):1189-1199. PubMed ID: 37851052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus.
    Gavvovidis I; Leisegang M; Willimsky G; Miller N; Nghiem P; Blankenstein T
    Clin Cancer Res; 2018 Aug; 24(15):3644-3655. PubMed ID: 29669806
    [No Abstract]   [Full Text] [Related]  

  • 25. Case Report: Exceptional Response to Avelumab After Failure of Electrochemotherapy in a Patient With Rapidly Progressive, PD-L1-Negative Merkel Cell Carcinoma.
    Torchio M; Cattaneo L; Milione M; Prinzi N; Corti F; Ungari M; Anichini A; Mortarini R; Occhini A; Bertino G; Maurichi A; Coppa J; Di Bartolomeo M; de Braud FG; Pusceddu S
    Front Oncol; 2021; 11():628324. PubMed ID: 34221958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
    Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes.
    Kumar S; Xie H; Shi H; Gao J; Juhlin CC; Björnhagen V; Höög A; Lee L; Larsson C; Lui WO
    Int J Cancer; 2020 Mar; 146(6):1652-1666. PubMed ID: 31180579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of six Merkel cell polyomavirus-positive Merkel cell carcinoma cell lines: Integration pattern suggest that large T antigen truncating events occur before or during integration.
    Schrama D; Sarosi EM; Adam C; Ritter C; Kaemmerer U; Klopocki E; König EM; Utikal J; Becker JC; Houben R
    Int J Cancer; 2019 Aug; 145(4):1020-1032. PubMed ID: 30873613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
    D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
    Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
    Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
    Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
    Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis.
    Harms PW; Patel RM; Verhaegen ME; Giordano TJ; Nash KT; Johnson CN; Daignault S; Thomas DG; Gudjonsson JE; Elder JT; Dlugosz AA; Johnson TM; Fullen DR; Bichakjian CK
    J Invest Dermatol; 2013 Apr; 133(4):936-45. PubMed ID: 23223137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyomavirus-driven Merkel cell carcinoma: Prospects for therapeutic vaccine development.
    Tabachnick-Cherny S; Pulliam T; Church C; Koelle DM; Nghiem P
    Mol Carcinog; 2020 Jul; 59(7):807-821. PubMed ID: 32219902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.
    Gaiser MR; Bongiorno M; Brownell I
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):345-359. PubMed ID: 29478343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
    Topalian SL; Bhatia S; Amin A; Kudchadkar RR; Sharfman WH; Lebbé C; Delord JP; Dunn LA; Shinohara MM; Kulikauskas R; Chung CH; Martens UM; Ferris RL; Stein JE; Engle EL; Devriese LA; Lao CD; Gu J; Li B; Chen T; Barrows A; Horvath A; Taube JM; Nghiem P
    J Clin Oncol; 2020 Aug; 38(22):2476-2487. PubMed ID: 32324435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma.
    Soikkeli AI; Kyläniemi MK; Sihto H; Alinikula J
    Cancer Res Commun; 2022 Nov; 2(11):1344-1354. PubMed ID: 36970060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
    Nghiem PT; Bhatia S; Lipson EJ; Kudchadkar RR; Miller NJ; Annamalai L; Berry S; Chartash EK; Daud A; Fling SP; Friedlander PA; Kluger HM; Kohrt HE; Lundgren L; Margolin K; Mitchell A; Olencki T; Pardoll DM; Reddy SA; Shantha EM; Sharfman WH; Sharon E; Shemanski LR; Shinohara MM; Sunshine JC; Taube JM; Thompson JA; Townson SM; Yearley JH; Topalian SL; Cheever MA
    N Engl J Med; 2016 Jun; 374(26):2542-52. PubMed ID: 27093365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell analysis reveals clonally expanded tumor-associated CD57
    Fehlings M; Kim L; Guan X; Yuen K; Tafazzol A; Sanjabi S; Zill OA; Rishipathak D; Wallace A; Nardin A; Ma S; Milojkovic A; Newell EW; Mariathasan S; Yadav M
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35981786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of Merkel cell polyomavirus positivity with PDGFRα mutations and survivin expression in Merkel cell carcinoma.
    Batinica M; Akgül B; Silling S; Mauch C; Zigrino P
    J Dermatol Sci; 2015 Jul; 79(1):43-9. PubMed ID: 25936870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.